Hereditary tyrosinemia, type I

Clinical trials for Hereditary tyrosinemia, type I explained in plain language.

Never miss a new study

Get alerted when new Hereditary tyrosinemia, type I trials appear

Sign up with your email to follow new studies for Hereditary tyrosinemia, type I, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

HT-1 drug study in china withdrawn before starting

Knowledge-focused Cancelled

This study was designed to observe how patients with hereditary tyrosinemia type 1 (HT-1) in China respond to nitisinone treatment in everyday medical practice. It planned to track serious health events like liver problems or death. However, the study was withdrawn before enrolli…

Matched conditions: HEREDITARY TYROSINEMIA, TYPE I

Sponsor: Swedish Orphan Biovitrum • Aim: Knowledge-focused

Last updated Jun 27, 2026 08:06 UTC

Hereditary tyrosinemia, type I

Get alerted when new Hereditary tyrosinemia, type I trials appear

HT-1 drug study in china withdrawn before starting